Head of Corporate Strategy and Business Development

ABOUT INOGRAFTInograft Biotherapeutics, Inc. is a preclinical-stage biotechnology company focused on the development of best-in-class non-genotoxic bone marrow conditioning regimens for stem cell transplantation. Formed in late 2022, with founders from Stanford University School of Medicine and Forty Seven Inc. (acquired by Gilead in 2020 for $4.9B), Inograft aims to develop life-changing therapies by applying proven stem cell therapies to areas of significant unmet medical need, including genetic disorders, autoimmune diseases, aging, and organ transplant.We are seeking a head of Corporate Strategy and Business Development who will lead the development and implementation of short and long-range strategies at the program level (new product planning), portfolio level, and for external collaborations and partnerships. This individual will report to the Chief Executive Officer and work closely with the leadership team and other key stakeholders to identify, evaluate, and prioritize high-value opportunity areas for Inograft.ResponsibilitiesCorporate Strategy:New product planning: Work cross-functionally to develop strategic direction and actionable objectives for each programConduct high-quality opportunity assessments and reviews to identify an initial development path for each program aligned with a broader, longer-term visionPortfolio planning: Lead a portfolio review process at the appropriate timing cadence, bringing together scientific rigor and business perspectives to support robust decision making and prioritization of resources across all programs within the portfolioWork closely with Research, Finance, and other core functions to ensure implementation of prioritization decisionsDemonstrate ability to engage and effectively influence members across diverse teamsDrive curiosity, scientific rigor, and excellent problem-solving skills across a fast-paced, performance-driven environmentBusiness Development:Lead activities to access external capabilities and technologies, including the sourcing, evaluation and negotiation of in-licensing, collaboration, and out-licensing dealsSupport creative deal & collaboration structures aligned with scientific and business needs and make recommendations to key leadership team members and Board stakeholdersDevelop and oversee the execution of short and long-range business development strategies aligned with the priorities of Inografts corporate strategyEstablish collaborative relationships with key internal functions (R&D, Legal and Finance) to ensure strong relationships with and support for the BD transactionsQualifications15+ years industry experience in the biotechnology, pharmaceutical, or other healthcare fieldAdvanced degree (PhD, MD, MBA, or equivalent) preferred, or significant relevant industry experience and scientific acumenAbility to think strategically and analytically, with a track record of identifying, evaluating, and aligning organizations on high-value opportunities areasExperience in a Commercial Strategy or New Product Planning role, including leading corporate level Portfolio / Business Review processesExperience sourcing, constructing, and closing collaboration deals, including running cross functional due diligence and financial analysis & modellingExperience leading broad organizational initiatives and working with cross-functional teamsStrong decision-maker able to appropriately articulate and balance tradeoffs in areas of high complexityExcellent interpersonal and organizational skillsStrong communication, conflict resolution, and leadership skillsInograft offers a competitive salary and benefits package.The anticipated salary range for this position is $325,000 to $373,000. The actual salary may vary based on various factors including but not limited to experience level, knowledge, relevant skills and qualifications.Please send resumes to careers@.

Created: 2025-02-20